ÂÜÀòÂÒÂ×

Mark Lewis currently serves as Vice President of Finance and Business Operations at Wugen and as a Venture Capital Fellow at BioGenerator. Prior experience includes a role as a Graduate Research Associate in Gastroenterology at Washington University in St. Louis, where work focused on bioinformatics related to organ injury models under the mentorship of Dr. Jason Mills. Earlier, Mark Lewis held multiple research associate positions at Monsanto, specializing in genome and molecular analysis as well as cell culture. Mark Lewis holds a PhD in Cellular and Molecular Biology and an MS in Biology from Washington University School of Medicine in St. Louis, as well as a BS in Biochemistry from Eastern Connecticut State University.